An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
Novo Nordisk shares tumbled last year when obesity candidate CagriSema failed to clear a weight loss bar of 25%. Now, ...
Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...
Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...
8h
News Medical on MSNVision loss risks in patients using popular GLP-1 medications raise concernsA small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
21h
Hosted on MSNWe Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
12h
Verywell Health on MSNDoes Berberine Really Aid Weight Loss? A Registered Dietitian ExplainsThe body does not absorb berberine well, limiting its ability to affect body weight significantly. However, berberine may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results